Subarachnoid Hemorrhage, Aneurysmal
Conditions
Brief summary
The investigators are planning that can these markers be used a predictive marker at SAH and for this aim we will study both patiens' blood sample and their CT image.
Detailed description
An ideal marker which could be used clinically should meet numerous criteria, such as high sensitivity or the possibility of easy and quick assessment of its concentration in blood or blood plasma.The Fisher's scale presents an alternative for evaluating patients with subarachnoid hemorrhage . The investigator are going to evaluate both plasma markers and fishers scale at SAH.
Interventions
DIAGNOSTIC_TESTBezmialem VAkif Unv. Ethical board
If ıs any trials not convenient to Helsinki Agrement about Human research rules
Sponsors
Bezmialem Vakif University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Ruptured Subarachnoid Aneursym
Exclusion criteria
* without aneursymal sah * Patient's positive for rheumatoid factor and anti-CCP or with chronic inflammatory diseases (such as ankylosing spondylitis or rheumatoid arthritis), systemic diseases (such as hypercholesterolemia, hypertension, diabetes mellitus, myocardial infarction, stroke, peripheral artery disease), active infection, a history of term medication, trauma to the hip and smoking were excluded from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic marker identification | 24 months | Evaluation of the concentration levels of enflamation markers relation with Sur1 TRPM+ molecules, together with the values of global tests of coagulation system, may serve as a helpful SAH diagnostic marker. |
Outcome results
None listed